Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Levosalbutamol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 10/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.75 |
| ▸ | TSHR | P16473 | 4/20 | 0.75 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.75 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CASP7 | P55210 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.53 |
| ▸ | MTOR | P42345 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albuterol SCHEMBL9238360 | 1.00 | ADRB2 (0.75) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL328959 | 0.93 | ADRB2 (0.87) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL5657533 | 0.91 | ADRB2 (0.79) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Terbutaline SCHEMBL1417928 | 0.88 | ADRB2 (0.70) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL9545560 | 0.87 | ADRB2 (0.72) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL2489838 | 0.87 | ADRB2 (1.00) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Levosalbutamol SCHEMBL4003 | 0.87 | ADRB2 (1.00) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL121596 | 0.87 | ADRB2 (1.00) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL4913 | 0.87 | ADRB2 (1.00) | ADRB2HIF1ATSHRADRB1CYP1A2 | |
| Albuterol SCHEMBL122805 | 0.87 | ADRB2 (1.00) | ADRB2HIF1ATSHRADRB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9820954-B2 | Quantitative peri-orbital application of ophthalmology drugs | JENIVISION INC. (US) | 2017-11-21 | — | — | US | disclosed |
| US-20170049734-A1 | QUANTITATIVE PERI-ORBITAL APPLICATION OF OPHTHALMOLOGY DRUGS | JENIVISION INC. | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170049734-A1 | QUANTITATIVE PERI-ORBITAL APPLICATION OF OPHTHALMOLOGY DRUGS | PTGIR, QDPR, PDE3A | ADRB2 76/4885HIF1A 1306/4885TSHR 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.